Wen Hong-wu, Huang Wei-ping, Liu Tong-yu, Ma Ke, Tao Xia, Zhu Li-rong, Liao Qin-ping
Department of Obstetrics and Gynecology, Peking University First Hospital,Beijing 100034, China. Email:
Zhonghua Fu Chan Ke Za Zhi. 2013 Dec;48(12):920-4.
To investigate the effects of postoperative adjuvant chemotherapy (CT) and chemoradiotherapy (CRT) or radiotherapy(RT) for Ib-IIa cervical cancer with risk factors.
From March 1995 to June 2010, there were 137 patients underwent radical hysterectomy and systematic pelvic lymphadenectomy for stage Ib-IIa cervical cancer admitted at Peking University First Hospital. These patients had risk factors, intermediate risk factors including bulky tumor ( > 4 cm) , lymph vascular space invasion, deep stromal invasion; high risk factors including positive surgical margin, parametrial invasion, lymph node involvement. Of the all patients, 79 cases of them were treated with CT, 58 of them were treated with RT or CRT. The 5-year survival and prognosis factors were analyzed retrospectively, the prognosis was compared between two adjuvant therapy groups.
The univariate analysis shown that types of pathology, different grade of risk factors, stroma invasion and lymph node involvement were prognostic factors of 5-year overall survival. Patients with squamous cell carcinoma, intermediate risk factors, no parametrial invasion, and no lymph node involvement had better prognosis(P < 0.05). Whether patients with high-risk factors or intermediate-risk factors, the 5-year overall survival and 3-year disease-free survival had no difference between CT and RCT or RT groups respectively. Cox regression multivariate analysis of survival indicated that clinical stages, types of histology, different grade of risk factors were independent prognostic indicator. Patients with early stage, squamous cell carcinoma, intermediate risk factors had better prognosis. Univariate and multivariate analysis indicated that different postoperative adjuvant therapies had no effects on the prognosis. The 5-year overall survival was 88.6% in patients treated with CT, and 89.7% in patients treated with RT or CRT (P = 0.455) .
There are equivalent therapeutic results between CT and RT or CRT for patients with risk factors after radical surgery, CT may be as one choice of postoperative adjuvant therapy for stage Ib-IIa cervical carcinoma with risk factors.
探讨术后辅助化疗(CT)、放化疗(CRT)或放疗(RT)对具有危险因素的Ib-IIa期宫颈癌的疗效。
1995年3月至2010年6月,北京大学第一医院收治的137例因Ib-IIa期宫颈癌接受根治性子宫切除术和系统性盆腔淋巴结清扫术的患者。这些患者具有危险因素,中度危险因素包括肿瘤体积大(>4cm)、淋巴管间隙浸润、深部间质浸润;高度危险因素包括手术切缘阳性、宫旁浸润、淋巴结受累。所有患者中,79例接受CT治疗,58例接受RT或CRT治疗。回顾性分析5年生存率及预后因素,比较两种辅助治疗组的预后情况。
单因素分析显示,病理类型、不同等级的危险因素、间质浸润和淋巴结受累是5年总生存的预后因素。鳞状细胞癌、中度危险因素、无宫旁浸润且无淋巴结受累的患者预后较好(P<0.05)。无论高危因素还是中度危险因素患者,CT组与RCT或RT组的5年总生存率和3年无病生存率分别无差异。生存的Cox回归多因素分析表明,临床分期、组织学类型、不同等级的危险因素是独立预后指标。早期、鳞状细胞癌、中度危险因素的患者预后较好。单因素和多因素分析表明,不同的术后辅助治疗对预后无影响。CT治疗患者的5年总生存率为88.6%,RT或CRT治疗患者为89.7%(P=0.455)。
根治性手术后具有危险因素的患者,CT与RT或CRT的治疗效果相当,CT可作为具有危险因素的Ib-IIa期宫颈癌术后辅助治疗的一种选择。